A NOVEL NONPEPTIDIC, ORALLY ACTIVE RENIN INHIBITOR

被引：32

作者：

MORISHIMA, H ^{[1
]}

KOIKE, Y ^{[1
]}

NAKANO, M ^{[1
]}

ATSUUMI, S ^{[1
]}

TANAKA, S ^{[1
]}

FUNABASHI, H ^{[1
]}

HASHIMOTO, J ^{[1
]}

SAWASAKI, Y ^{[1
]}

MINO, N ^{[1
]}

NAKANO, M ^{[1
]}

MATSUSHIMA, K ^{[1
]}

NAKAMICHI, K ^{[1
]}

YANO, M ^{[1
]}

机构：

[1] BANYO PHARMACEUT CO LTD, CENT RES LABS,MEGURO KU, TOKYO 1531, JAPAN

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1989年 / 159卷 / 03期

关键词：

D O I：

10.1016/0006-291X(89)92207-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：999 / 1005

页数：7

共 50 条

[21] Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists
Riechers, H
Albrecht, HP
Amberg, W
Baumann, E
Bernard, H
Bohm, HJ
Klinge, D
Kling, A
Muller, S
Raschack, M
Unger, L
Walker, N
Wernet, W
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (11) : 2123 - 2128
[22] TERLAKIREN - AN ORALLY-ACTIVE RENIN INHIBITOR IN THE GUINEA-PIG
MANGIAPANE, ML
WESTER, RT
HOLT, WF
ELLERY, SS
SIMPSON, KA
SCHELHORN, TM
SMITH, AH
PURCELL, IM
MURPHY, WR
DRUG DEVELOPMENT RESEARCH, 1995, 34 (04) : 361 - 368
[23] DISCOVERY OF REMIKIREN AS THE 1ST ORALLY ACTIVE RENIN INHIBITOR
CLOZEL, JP
FISCHLI, W
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1993, 43-1 (2A): : 260 - 262
[24] PHARMACOLOGY OF AN ORALLY-ACTIVE RENIN INHIBITOR, SC-56525
YANG, PC
BABLER, M
BITTNER, S
SULEYMANOY, O
PEREZ, M
CAINJANICKI, K
BEDEL, L
HANSON, G
COOK, C
OTTINGER, J
BARAN, J
MCMAHON, E
FASEB JOURNAL, 1994, 8 (05): : A882 - A882
[25] Excretion and metabolism of remikiren, a potent orally active inhibitor of primate renin
Jauch, R
Schmid, P
Fischli, W
Meister, W
Maurer, R
Wendt, G
XENOBIOTICA, 1996, 26 (03) : 285 - 295
[26] Iminopyrimidinones: A novel pharmacophore for the development of orally active renin inhibitors
McKittrick, Brian A.
Caldwell, John P.
Bara, Thomas
Boykow, George
Chintala, Madhu
Clader, John
Czarniecki, Michael
Courneya, Brandy
Duffy, Ruth
Fleming, Linda
Giessert, Rachel
Greenlee, William J.
Heap, Charles
Hong, Liwu
Huang, Ying
Iserloh, Ulrich
Josien, Hubert
Khan, Tanweer
Korfmacher, Walter
Liang, Xian
Mazzola, Robert
Mitra, Soumya
Moore, Kristina
Orth, Peter
Rajagopalan, Murali
Roy, Sudipta
Sakwa, Samuel
Strickland, Corey
Vaccaro, Henry
Voigt, Johannes
Wang, Hongwu
Wong, Jesse
Zhang, Rumin
Zych, Andrew
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (07) : 1592 - 1596
[27] CARDIOVASCULAR EFFECTS AND HEMODYNAMIC MECHANISM OF ACTION OF THE NOVEL, NONPEPTIDIC RENIN INHIBITOR A-74273 IN DOGS
WESSALE, JL
CALZADILLA, SV
BOYD, SA
BAKER, WR
STEIN, HH
KOVAR, PJ
BARLOW, J
KLINGHOFER, V
MANTEI, R
KLEINERT, HD
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (04) : 644 - 652
[28] RO-42-5892 IS A POTENT ORALLY ACTIVE RENIN INHIBITOR IN PRIMATES
FISCHLI, W
CLOZEL, JP
ELAMRANI, K
WOSTL, W
NEIDHART, W
STADLER, H
BRANCA, Q
HYPERTENSION, 1991, 18 (01) : 22 - 31
[29] MACROCYCLIC RENIN INHIBITORS - SYNTHESIS OF A SUBNANOMOLAR, ORALLY ACTIVE CYSTEINE DERIVED INHIBITOR
YANG, LH
WEBER, AE
DOYLE, JJ
SCHORN, TW
SIEGL, PKS
HALGREN, TA
GREENLEE, WJ
PATCHETT, AA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 122 - MEDI
[30] BILA 2157 BS (RI) is a potent, orally active renin inhibitor.
Panzenbeck, MJ
Madwed, J
Harrison, P
Weldon, SM
Kerr, S
Frei, P
Fogal, SE
Miner, E
Desai, S
Thibeault, D
Simoneau, B
Jung, GL
Lavallee, P
Anderson, PC
Winquist, RJ
FASEB JOURNAL, 1996, 10 (03): : 4030 - 4030

← 1 2 3 4 5 →